Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension.
Ochi H, Niino M, Onizuka Y, Hiramatsu K, Hase M, Yun J, Matta A, Torii S. Ochi H, et al. Among authors: matta a. Adv Ther. 2018 Oct;35(10):1598-1611. doi: 10.1007/s12325-018-0788-8. Epub 2018 Sep 11. Adv Ther. 2018. PMID: 30206820 Free PMC article. Clinical Trial.
Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice.
Mehta D, Miller C, Arnold DL, Bame E, Bar-Or A, Gold R, Hanna J, Kappos L, Liu S, Matta A, Phillips JT, Robertson D, von Hehn CA, Campbell J, Spach K, Yang L, Fox RJ. Mehta D, et al. Among authors: matta a. Neurology. 2019 Apr 9;92(15):e1724-e1738. doi: 10.1212/WNL.0000000000007262. Epub 2019 Mar 27. Neurology. 2019. PMID: 30918100 Free PMC article.
Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled study.
Mori M, Ohashi T, Onizuka Y, Hiramatsu K, Hase M, Yun J, Matta A, Torii S. Mori M, et al. Among authors: matta a. Mult Scler J Exp Transl Clin. 2019 Jun 10;5(2):2055217319852727. doi: 10.1177/2055217319852727. eCollection 2019 Apr-Jun. Mult Scler J Exp Transl Clin. 2019. PMID: 31218077 Free PMC article.
Efficacy of dimethyl fumarate in Japanese multiple sclerosis patients: interim analysis of randomized, double-blind APEX study and its open-label extension.
Kondo T, Kawachi I, Onizuka Y, Hiramatsu K, Hase M, Yun J, Matta A, Torii S. Kondo T, et al. Among authors: matta a. Mult Scler J Exp Transl Clin. 2019 Jul 31;5(3):2055217319864974. doi: 10.1177/2055217319864974. eCollection 2019 Jul-Sep. Mult Scler J Exp Transl Clin. 2019. PMID: 31391949 Free PMC article.
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial.
Reich DS, Arnold DL, Vermersch P, Bar-Or A, Fox RJ, Matta A, Turner T, Wallström E, Zhang X, Mareš M, Khabirov FA, Traboulsee A; Tolebrutinib Phase 2b Study Group. Reich DS, et al. Among authors: matta a. Lancet Neurol. 2021 Sep;20(9):729-738. doi: 10.1016/S1474-4422(21)00237-4. Lancet Neurol. 2021. PMID: 34418400 Free PMC article. Clinical Trial.
Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
Honig LS, Sabbagh MN, van Dyck CH, Sperling RA, Hersch S, Matta A, Giorgi L, Gee M, Kanekiyo M, Li D, Purcell D, Dhadda S, Irizarry M, Kramer L. Honig LS, et al. Among authors: matta a. Alzheimers Res Ther. 2024 May 10;16(1):105. doi: 10.1186/s13195-024-01441-8. Alzheimers Res Ther. 2024. PMID: 38730496 Free PMC article. Clinical Trial.
No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° South.
Fragoso YD, Adoni T, Alves-Leon SV, Apostolos-Pereira SL, Arruda WO, Brooks JB, Cal HS, Damasceno CA, Gama PD, Goncalves MV, Jesus CA, Machado SC, Mansur LF, Matta AP, Mendes MF, Morales RR, Nobrega AW Jr, Parolin MK, Peres MP, Ribeiro MC, Ruocco HH, Scherpenhuijzen S, Siquinelli F, Stoney PN, Varela DL, Eboni AC, Spessotto CV, Rocha ET, Lacerda PE. Fragoso YD, et al. Among authors: matta ap. Arq Neuropsiquiatr. 2017 Jan;75(1):3-8. doi: 10.1590/0004-282X20160173. Arq Neuropsiquiatr. 2017. PMID: 28099554 Free article.
276 results